Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00TYW
|
|||
| Former ID |
DNC003904
|
|||
| Drug Name |
6-Heptyl-4-hydroxy-3-octanoyl-pyran-2-one
|
|||
| Synonyms |
CHEMBL269138; 6-Heptyl-4-hydroxy-3-octanoyl-pyran-2-one; SCHEMBL10337594; BDBM50024653
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H32O4
|
|||
| Canonical SMILES |
CCCCCCCC1=CC(=C(C(=O)O1)C(=O)CCCCCCC)O
|
|||
| InChI |
1S/C20H32O4/c1-3-5-7-9-11-13-16-15-18(22)19(20(23)24-16)17(21)14-12-10-8-6-4-2/h15,22H,3-14H2,1-2H3
|
|||
| InChIKey |
UXMFHBGEDUHLJO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Neutrophil elastase (NE) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Transcriptional misregulation in cancer | |||
| Systemic lupus erythematosus | ||||
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||
| C-MYB transcription factor network | ||||
| Reactome | Collagen degradation | |||
| Degradation of the extracellular matrix | ||||
| Activation of Matrix Metalloproteinases | ||||
| WikiPathways | Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||
| Human Complement System | ||||
| Degradation of collagen | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibition of human sputum elastase by substituted 2-pyrones. J Med Chem. 1987 Jun;30(6):1017-23. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.